Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schmidt, M; Boehm, D; Lebrecht, A et al.
Immunoglobulin Kappa C Has Independent Prognostic Significance in Node-Negative Breast CancerCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 729S-729S
Schmidt, M; Petry, IB; Bohm, D et al.
Influence of Immunoglobulin Kappa C on the metastasis-free survival in adjuvant untreated node-negative Breast cancer.GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 69. H. 8. 2009 S. 759-759
Skala, CE; Petry, IB; Gebhard, S et al.
Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.Regen Med. Bd. 4. H. 2. 2009 S. 197-204
Naumann, G
Ist eine chirurgische Therapie der Mischinkontinenz sinnvoll?F. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Naumann, G
Kann die Belastungsinkontinenz der Frau medikamentös behandelt werden?F.Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. München: Deutscher Ärzteverlag 2009
Schmidt, M; Victor, A; Bratzel, D et al.
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-025EFcomparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trialANNALS OF ONCOLOGY. Bd. 20. H. 2. 2009 S. 258-264
Schmidt, M; Seraphin, J; Luhn, B et al.
Major issues in the treatment of metastatic bone disease: renal safety and maintained bone pain effectiveness of ibandronate in breast cancer patients in clinical practice; interim results of a non interventional study in GermanyCANCER RESEARCH. Bd. 69. H. 2. 2009 S. 154S-154S
Hampel, C; Naumann, G; Thüroff, JW et al.
Management of complications after sling and mesh implantationsUrologe A. Bd. 48. H. 5. 2009 S. 496-509
Schmidt, M; Tramm, T; Bohm, D et al.
Molecular breast cancer prognosis in node negative early breast cancerCANCER RESEARCH. Bd. 69. H. 2. 2009 S. 127S-127S
Harbeck, N; Meisner, C; Ravdin, PM et al.
Outcome Prediction in Node-Negative Breast Cancer Based on ASCO-Recommended Biomarkers uPA/PAI-1 Using the Final 10-Year Analysis of the Randomized Multicenter Chemo N0 Trial Compared to Adjuvant Online (TM)CANCER RESEARCH. Bd. 69. H. 24. 2009 S. 719S-719S